MYC and diffuse large B-cell lymphoma: Similarly, miR-124-3p suppresses DLBCL growth by inhibiting the NFATc1/c-MYC signaling axis, leading to reduced proliferation and increased apoptosis in both in vitro and in vivo models [124,125].